{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T11:02:53Z","timestamp":1781348573617,"version":"3.54.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2015,7,23]],"date-time":"2015-07-23T00:00:00Z","timestamp":1437609600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch. Pharm. Res."],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1007\/s12272-015-0627-2","type":"journal-article","created":{"date-parts":[[2015,7,22]],"date-time":"2015-07-22T00:51:22Z","timestamp":1437526282000},"page":"1718-1727","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Drug compound characterization by mass spectrometry imaging in cancer tissue"],"prefix":"10.1007","volume":"38","author":[{"given":"Ho Jeong","family":"Kwon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonghyo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Sugihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Baldetorp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Welinder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken-ichi","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihide","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Malm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Szilvia","family":"T\u00f6r\u00f6k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bal\u00e1zs","family":"D\u00f6me","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1kos","family":"V\u00e9gv\u00e1ri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Gustavsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas E.","family":"Fehniger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gy\u00f6rgy","family":"Marko-Varga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,7,23]]},"reference":[{"issue":"10","key":"627_CR1","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1111\/iju.12187","volume":"20","author":"H Abe","year":"2013","unstructured":"Abe, H., and T. Kamai. 2013. Recent advances in the treatment of metastatic renal cell carcinoma. International Journal of Urolology 20(10): 944\u2013955.","journal-title":"International Journal of Urolology"},{"issue":"11","key":"627_CR2","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1517\/13543780903336050","volume":"18","author":"E Amir","year":"2009","unstructured":"Amir, E., L. Mandoky, F. Blackhall, N. Thatcher, W. Klepetko, H.J. Ankersmit, M.A. Reza Hoda, G. Ostoros, M. Dank, and B. Dome. 2009. Antivascular agents for non-small-cell lung cancer: current status and future directions. Expert Opinion on Investigational Drugs 18(11): 1667\u20131686.","journal-title":"Expert Opinion on Investigational Drugs"},{"issue":"7401","key":"627_CR3","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/486141a","volume":"486","author":"M Baker","year":"2012","unstructured":"Baker, M. 2012. Biorepositories: Building better biobanks. Nature 486(7401): 141\u2013146. \u00a0","journal-title":"Nature"},{"issue":"36","key":"627_CR54","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1200\/JCO.2009.23.4799","volume":"27","author":"CM Balch","year":"2009","unstructured":"Balch, C.M., J.E. Gershenwald, S.J. Soong, J.F. Thompson, M.B. Atkins, D.R. Byrd, A.C. Buzaid, A.J. Cochran, D.G. Coit, S. Ding, A.M. Eggermont, K.T. Flaherty, P.A. Gimotty, J.M. Kirkwood, K.M. McMasters, M.C.Jr. Mihm, D.L. Morton, M.I. Ross, A.J. Sober, and V.K. Sondak. 2009. Final version of 2009 AJCC melanoma staging and classification.\u00a0Journal of Clinical Oncology\u00a027(36): 6199\u20136206.","journal-title":"Journal of Clinical Oncology"},{"issue":"7315","key":"627_CR4","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/nature09454","volume":"467","author":"G Bollag","year":"2010","unstructured":"Bollag, G., P. Hirth, J. Tsai, J. Zhang, P.N. Ibrahim, H. Cho, W. Spevak, C. Zhang, Y. Zhan, G. Habets, E.A. Burton, B. Wong, G. Tsang, B.L. West, B. Powell, R. Shellooe, A. Marimuthu, H. Nguyen, K.Y. Zhang, D.R. Artis, J. Schlessinger, F. Su, B. Higgins, R. Iyer, K. D\u2019Andrea, A. Koehler, M. Stumm, P.S. Lin, R.J. Lee, J. Grippo, I. Puzanov, K.B. Kim, A. Ribas, G.A. McArthur, J.A. Sosman, P.B. Chapman, K.T. Flaherty, X. Xu, K.L. Nathanson, and K. Nolop. 2010. Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma. Nature 467(7315): 596\u2013599.","journal-title":"Nature"},{"issue":"8","key":"627_CR5","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1007\/s00216-014-8237-2","volume":"407","author":"A Buck","year":"2015","unstructured":"Buck, A., S. Halbritter, C. Spath, A. Feuchtinger, M. Aichler, H. Zitzelsberger, K.P. Janssen, and A. Walch. 2015. Distribution and quantification of irinotecan and its active metabolite SN-38 in colon cancer murine model systems using MALDI MSI. Analytical and Bioanalytical Chemistry 407(8): 2107\u20132116.","journal-title":"Analytical and Bioanalytical Chemistry"},{"issue":"2","key":"627_CR6","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1021\/tx3004196","volume":"26","author":"S Castellino","year":"2013","unstructured":"Castellino, S., M.R. Groseclose, J. Sigafoos, D. Wagner, M. de Serres, J.W. Polli, E. Romach, J. Myer, and B. Hamilton. 2013. Central nervous system disposition and metabolism of Fosdevirine (GSK2248761), a non-nucleoside reverse transcriptase inhibitor: An LC-MS and Matrix-assisted laser desorption\/ionization imaging MS investigation into central nervous system toxicity. Chemical Research in Toxicology 26(2): 241\u2013251.","journal-title":"Chemical Research in Toxicology"},{"issue":"26","key":"627_CR7","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1056\/NEJMoa1103782","volume":"364","author":"PB Chapman","year":"2011","unstructured":"Chapman, P.B., A. Hauschild, C. Robert, J.B. Haanen, P. Ascierto, J. Larkin, R. Dummer, C. Garbe, A. Testori, M. Maio, M. Hogg, P. Lorigan, C. Lebbe, T. Jouary, D. Schadendorf, A. Ribas, S.J. O\u2019Day, J.A. Sosman, J.M. Kirkwood, A.M. Eggermont, B. Dreno, K. Nolop, J. Li, B. Nelson, J. Hou, R.J. Lee, K.T. Flaherty, G.A. McArthur, and BRISM-3 Study Group. 2011. Improved survival with vemurafenib in melanoma with BRAF V600E mutation. New England Journal of Medicine 364(26): 2507\u20132516.","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"627_CR8","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1074\/mcp.M700190-MCP200","volume":"7","author":"P Chaurand","year":"2008","unstructured":"Chaurand, P., M.A. Rahman, T. Hunt, J.A. Mobley, G. Gu, J.C. Latham, R.M. Caprioli, and S. Kasper. 2008. Monitoring mouse prostate development by profiling and imaging mass spectrometry. Molecular and Cellular Proteomics 7(2): 411\u2013423.","journal-title":"Molecular and Cellular Proteomics"},{"issue":"23","key":"627_CR9","doi-asserted-by":"crossref","first-page":"11576","DOI":"10.1021\/ac402777k","volume":"85","author":"DF Cobice","year":"2013","unstructured":"Cobice, D.F., C.L. Mackay, R.J. Goodwin, A. McBride, P.R. Langridge-Smith, S.P. Webster, B.R. Walker, and R. Andrew. 2013. Mass spectrometry imaging for dissecting steroid intracrinology within target tissues. Analytical Chemistry 85(23): 11576\u201311584.","journal-title":"Analytical Chemistry"},{"issue":"4","key":"627_CR10","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1744-1609.2011.00239.x","volume":"9","author":"D Dwyer","year":"2011","unstructured":"Dwyer, D. 2011. Experiences of registered nurses as managers and leaders in residential aged care facilities: A systematic review. International Journal of Evidence Based Healthcare 9(4): 388\u2013402.","journal-title":"International Journal of Evidence Based Healthcare"},{"issue":"21","key":"627_CR11","doi-asserted-by":"crossref","first-page":"8329","DOI":"10.1021\/ac2014349","volume":"83","author":"TE Fehniger","year":"2011","unstructured":"Fehniger, T.E., A. Vegvari, M. Rezeli, K. Prikk, P. Ross, M. Dahlback, G. Edula, R. Sepper, and G. Marko-Varga. 2011. Direct demonstration of tissue uptake of an inhaled drug: Proof-of-principle study using matrix-assisted laser desorption ionization mass spectrometry imaging. Analalytical Chemistry 83(21): 8329\u20138336.","journal-title":"Analalytical Chemistry"},{"issue":"12","key":"627_CR12","doi-asserted-by":"crossref","first-page":"5310","DOI":"10.1021\/pr500472d","volume":"13","author":"TE Fehniger","year":"2014","unstructured":"Fehniger, T.E., E.S. Boja, H. Rodriguez, M.S. Baker, and G. Marko-Varga. 2014. Four areas of engagement requiring strengthening in modern proteomics today. Journal of Proteome Research 13(12): 5310\u20135318.","journal-title":"Journal of Proteome Research"},{"issue":"1","key":"627_CR13","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s12265-009-9158-x","volume":"3","author":"Y Fu","year":"2010","unstructured":"Fu, Y., D. Kedziorek, and D.L. Kraitchman. 2010. Recent developments and future challenges on imaging for stem cell research. Journal of Cardiovascular and Translational Research 3(1): 24\u201329.","journal-title":"Journal of Cardiovascular and Translational Research"},{"issue":"2","key":"627_CR14","doi-asserted-by":"crossref","first-page":"e90242","DOI":"10.1371\/journal.pone.0090242","volume":"9","author":"T Goto","year":"2014","unstructured":"Goto, T., N. Terada, T. Inoue, K. Nakayama, Y. Okada, T. Yoshikawa, Y. Miyazaki, M. Uegaki, S. Sumiyoshi, T. Kobayashi, T. Kamba, K. Yoshimura, and O. Ogawa. 2014. The expression profile of phosphatidylinositol in high spatial resolution imaging mass spectrometry as a potential biomarker for prostate cancer. PLoS ONE 9(2): e90242.","journal-title":"PLoS ONE"},{"issue":"1","key":"627_CR15","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/path.4318","volume":"233","author":"K Harbst","year":"2014","unstructured":"Harbst, K., M. Lauss, H. Cirenajwis, C. Winter, J. Howlin, T. T\u00f6rngren, A. Kvist, B. Nodin, E. Olsson, J. H\u00e4kkinen, K. Jirstr\u00f6m, J. Staaf, L. Lundgren, H. Olsson, C. Ingvar, S.K. Gruvberger-Saal, L.H. Saal, and G. J\u00f6nsson. 2014. Molecular and genetic diversity in the metastatic process of melanoma. Journal of Pathology 233(1): 39\u201350.","journal-title":"Journal of Pathology"},{"issue":"3","key":"627_CR16","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1007\/s00216-008-1972-5","volume":"391","author":"WM Hardesty","year":"2008","unstructured":"Hardesty, W.M., and R.M. Caprioli. 2008. In situ molecular imaging of proteins in tissues using mass spectrometry. Analytical and Bioanalytical Chemistry 391(3): 899\u2013903.","journal-title":"Analytical and Bioanalytical Chemistry"},{"issue":"5","key":"627_CR17","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/nrclinonc.2012.8","volume":"9","author":"GC Jayson","year":"2012","unstructured":"Jayson, G.C., D.J. Hicklin, and L.M. Ellis. 2012. Antiangiogenic therapy\u2014evolving view based on clinical trial results. Nature Reviews Clinical Oncology 9(5): 297\u2013303.","journal-title":"Nature Reviews Clinical Oncology"},{"issue":"19","key":"627_CR18","doi-asserted-by":"crossref","first-page":"4601","DOI":"10.1007\/s00216-014-7880-y","volume":"406","author":"R Jirasko","year":"2014","unstructured":"Jirasko, R., M. Holcapek, M. Kunes, and A. Svatos. 2014. Distribution study of atorvastatin and its metabolites in rat tissues using combined information from UHPLC\/MS and MALDI-Orbitrap-MS imaging. Analytical and Bioanalytical Chemistry 406(19): 4601\u20134610.","journal-title":"Analytical and Bioanalytical Chemistry"},{"issue":"6","key":"627_CR19","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.jprot.2010.12.006","volume":"74","author":"H Kato","year":"2011","unstructured":"Kato, H., T. Nishimura, N. Ikeda, T. Yamada, T. Kondo, N. Saijo, K. Nishio, J. Fujimoto, M. Nomura, Y. Oda, B. Lindmark, J. Maniwa, H. Hibino, M. Unno, T. Ito, Y. Sawa, H. Tojo, S. Egawa, G. Edula, M. Lopez, M. Wigmore, N. Inase, Y. Yoshizawa, F. Nomura, and G. Marko-Varga. 2011. Developments for a growing Japanese patient population: Facilitating new technologies for future health care. Journal of Proteomics 74(6): 759\u2013764.","journal-title":"Journal of Proteomics"},{"issue":"4","key":"627_CR20","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/rcm.4891","volume":"25","author":"SL Koeniger","year":"2011","unstructured":"Koeniger, S.L., N. Talaty, Y. Luo, D. Ready, M. Voorbach, T. Seifert, S. Cepa, J.A. Fagerland, J. Bouska, W. Buck, R.W. Johnson, and S. Spanton. 2011. A quantitation method for mass spectrometry imaging. Rapid Communications in Mass Spectrometry 25(4): 503\u2013510.","journal-title":"Rapid Communications in Mass Spectrometry"},{"issue":"29","key":"627_CR21","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.2174\/138161205774580679","volume":"11","author":"JM Lanao","year":"2005","unstructured":"Lanao, J.M., and M.A. Fraile. 2005. Drug tissue distribution: Study methods and therapeutic implications. Current Pharmaceutical Design 11(29): 3829\u20133845.","journal-title":"Current Pharmaceutical Design"},{"issue":"6","key":"627_CR22","doi-asserted-by":"crossref","first-page":"463","DOI":"10.2174\/1389200043335379","volume":"5","author":"O Langer","year":"2004","unstructured":"Langer, O., and M. Muller. 2004. Methods to assess tissue-specific distribution and metabolism of drugs. Current Drug Metabolism 5(6): 463\u2013481.","journal-title":"Current Drug Metabolism"},{"issue":"1","key":"627_CR23","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/DAD.0b013e31823df1e2","volume":"34","author":"R Lazova","year":"2012","unstructured":"Lazova, R., E.H. Seeley, M. Keenan, R. Gueorguieva, and R.M. Caprioli. 2012. Imaging mass spectrometry\u2014A new and promising method to differentiate Spitz nevi from Spitzoid malignant melanomas. American Journal of Dermatopathology 34(1): 82\u201390.","journal-title":"American Journal of Dermatopathology"},{"key":"627_CR24","doi-asserted-by":"crossref","unstructured":"Legrain, P., R. Aebersold, A. Archakov, A. Bairoch, K. Bala, L. Beretta, J. Bergeron, C.H. Borchers, G.L. Corthals, C.E. Costello, E.W. Deutsch, B. Domon, W. Hancock, F. He, D. Hochstrasser, G. Marko-Varga, G.H. Salekdeh, S. Sechi, M. Snyder, S. Srivastava, M. Uhl\u00e9n, C.H. Wu, T. Yamamoto, Y.K. Paik, and G.S. Omenn. 2011. The human proteome project: current state and future direction. Molecular and Cellular Proteomics 10(7): M111 009993.","DOI":"10.1074\/mcp.M111.009993"},{"issue":"8","key":"627_CR25","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.addr.2013.04.009","volume":"65","author":"CB Lietz","year":"2013","unstructured":"Lietz, C.B., E. Gemperline, and L. Li. 2013. Qualitative and quantitative mass spectrometry imaging of drugs and metabolites. Advanced Drug Delivery Reveiws 65(8): 1074\u20131085.","journal-title":"Advanced Drug Delivery Reveiws"},{"key":"627_CR26","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1038\/srep02859","volume":"3","author":"X Liu","year":"2013","unstructured":"Liu, X., J.L. Ide, I. Norton, M.A. Marchionni, M.C. Ebling, L.Y. Wang, E. Davis, C.M. Sauvageot, S. Kesari, K.A. Kellersberger, M.L. Easterling, S. Santagata, D.D. Stuart, J. Alberta, J.N. Agar, C.D. Stiles, and N.Y. Agar. 2013. Molecular imaging of drug transit through the blood\u2013brain barrier with MALDI mass spectrometry imaging. Scientific Reports 3: 2859.","journal-title":"Scientific Reports"},{"issue":"1","key":"627_CR27","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1177\/1947601909356574","volume":"1","author":"S Loges","year":"2010","unstructured":"Loges, S., T. Schmidt, and P. Carmeliet. 2010. Mechanisms of resistance to anti-angiogenic therapy and development of third-generation anti-angiogenic drug candidates. Genes Cancer 1(1): 12\u201325.","journal-title":"Genes Cancer"},{"issue":"1","key":"627_CR28","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/2001-1326-1-8","volume":"1","author":"G Marko-Varga","year":"2012","unstructured":"Marko-Varga, G., A. Vegvari, M. Rezeli, K. Prikk, P. Ross, M. Dahlback, G. Edula, R. Sepper, and G. Marko-Varga. 2012. Understanding drug uptake and binding within targeted disease micro-environments in patients: a new tool for translational medicine. Clinical and Translational Medicine 1(1): 8.","journal-title":"Clinical and Translational Medicine"},{"issue":"1","key":"627_CR29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1021\/pr301183a","volume":"12","author":"G Marko-Varga","year":"2013","unstructured":"Marko-Varga, G., G.S. Omenn, Y.K. Paik, and W.S. Hancock. 2013. A first step toward completion of a genome-wide characterization of the human proteome. Journal of Proteome Research 12(1): 1\u20135.","journal-title":"Journal of Proteome Research"},{"issue":"12","key":"627_CR30","doi-asserted-by":"crossref","first-page":"5319","DOI":"10.1021\/pr500475q","volume":"13","author":"G Marko-Varga","year":"2014","unstructured":"Marko-Varga, G., M.S. Baker, E.S. Boja, H. Rodriguez, and T.E. Fehniger. 2014. Biorepository regulatory frameworks: Building parallel resources that both promote scientific investigation and protect human subjects. Journal of Proteome Research 13(12): 5319\u20135324.","journal-title":"Journal of Proteome Research"},{"issue":"14","key":"627_CR31","doi-asserted-by":"crossref","first-page":"3750","DOI":"10.1158\/1078-0432.CCR-11-1275","volume":"18","author":"V Moreno Garcia","year":"2012","unstructured":"Moreno Garcia, V., B. Basu, L.R. Molife, and S.B. Kaye. 2012. Combining antiangiogenics to overcome resistance: rationale and clinical experience. Clinical Cancer Research 18(14): 3750\u20133761.","journal-title":"Clinical Cancer Research"},{"issue":"2","key":"627_CR32","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/jac\/dkm476","volume":"61","author":"JW Mouton","year":"2008","unstructured":"Mouton, J.W., U. Theuretzbacher, W.A. Craig, P.M. Tulkens, H. Derendorf, and O. Cars. 2008. Tissue concentrations: Do we ever learn? Journal of Antimicrobial Chemotherapy 61(2): 235\u2013237.","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"7","key":"627_CR33","doi-asserted-by":"crossref","first-page":"e11411","DOI":"10.1371\/journal.pone.0011411","volume":"5","author":"A Nilsson","year":"2010","unstructured":"Nilsson, A., T.E. Fehniger, L. Gustavsson, M. Andersson, K. Kenne, G. Marko-Varga, and P.E. Andr\u00e9n. 2010. Fine mapping the spatial distribution and concentration of unlabeled drugs within tissue micro-compartments using imaging mass spectrometry. PLoS ONE 5(7): e11411.","journal-title":"PLoS ONE"},{"issue":"2","key":"627_CR34","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1021\/pr500564q","volume":"14","author":"CL Nilsson","year":"2015","unstructured":"Nilsson, C.L., E. Mostovenko, C.F. Lichti, K. Ruggles, D. Fenyo, K.R. Rosenbloom, W.S. Hancock, Y.K. Paik, G.S. Omenn, J. LaBaer, R.A. Kroes, M. Uhl\u00e9n, S. Hober, A. Vegvari, P.E. Andr\u00e9n, E.P. Sulman, F.F. Lang, M. Fuentes, E. Carlsohn, M.R. Emmett, J.R. Moskal, F.S. Berven, T.E. Fehniger, and G. Marko-Varga. 2015. Use of ENCODE resources to characterize novel proteoforms and missing proteins in the human proteome. Journal of Proteome Research 14(2): 603\u2013608.","journal-title":"Journal of Proteome Research"},{"issue":"1","key":"627_CR35","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s40169-014-0038-x","volume":"3","author":"T Nishimura","year":"2014","unstructured":"Nishimura, T., T. Kawamura, Y. Sugihara, Y. Bando, S. Sakamoto, M. Nomura, N. Ikeda, T. Ohira, J. Fujimoto, H. Tojo, T. Hamakubo, T. Kodama, R. Andersson, T.E. Fehniger, H. Kato, and G. Marko-Varga. 2014. Clinical initiatives linking Japanese and Swedish healthcare resources on cancer studies utilizing Biobank Repositories. Clinical and Translational Medicine 3(1): 61.","journal-title":"Clinical and Translational Medicine"},{"issue":"3","key":"627_CR36","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nbt.2152","volume":"30","author":"YK Paik","year":"2012","unstructured":"Paik, Y.K., S.K. Jeong, G.S. Omenn, M. Uhlen, S. Hanash, S.Y. Cho, H.J. Lee, K. Na, E.Y. Choi, F. Yan, F. Zhang, Y. Zhang, M. Snyder, Y. Cheng, R. Chen, G. Marko-Varga, E.W. Deutsch, H. Kim, J.Y. Kwon, R. Aebersold, A. Bairoch, A.D. Taylor, K.Y. Kim, E.Y. Lee, D. Hochstrasser, P. Legrain, and W.S. Hancock. 2012a. The Chromosome-Centric Human Proteome Project for cataloging proteins encoded in the genome. Nature Biotechnology 30(3): 221\u2013223.","journal-title":"Nature Biotechnology"},{"issue":"4","key":"627_CR37","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1021\/pr200824a","volume":"11","author":"YK Paik","year":"2012","unstructured":"Paik, Y.K., G.S. Omenn, M. Uhlen, S. Hanash, G. Marko-Varga, R. Aebersold, A. Bairoch, T. Yamamoto, P. Legrain, H.J. Lee, K. Na, S.K. Jeong, F. He, P.A. Binz, T. Nishimura, P. Keown, M.S. Baker, J.S. Yoo, J. Garin, A. Archakov, J. Bergeron, G.H. Salekdeh, and W.S. Hancock. 2012b. Standard guidelines for the chromosome-centric human proteome project. Journal of Proteome Research 11(4): 2005\u20132013.","journal-title":"Journal of Proteome Research"},{"issue":"1","key":"627_CR38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1021\/pr4011958","volume":"13","author":"YK Paik","year":"2014","unstructured":"Paik, Y.K., G.S. Omenn, V. Thongboonkerd, G. Marko-Varga, and W.S. Hancock. 2014. Genome-wide proteomics, Chromosome-Centric Human Proteome Project (C-HPP), part II. Journal of Proteome Research 13(1): 1\u20134.","journal-title":"Journal of Proteome Research"},{"issue":"2","key":"627_CR39","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1517\/17425255.2011.545053","volume":"7","author":"M Pellegatti","year":"2011","unstructured":"Pellegatti, M., and S. Pagliarusco. 2011. Drug and metabolite concentrations in tissues in relationship to tissue adverse findings: A review. Expert Opinion on Drug Metabolism and Toxicology 7(2): 137\u2013146.","journal-title":"Expert Opinion on Drug Metabolism and Toxicology"},{"issue":"7","key":"627_CR40","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/nrclinonc.2012.64","volume":"9","author":"A Rapisarda","year":"2012","unstructured":"Rapisarda, A., and G. Melillo. 2012. Overcoming disappointing results with antiangiogenic therapy by targeting hypoxia. Nature Reviews Clinical Oncology 9(7): 378\u2013390.","journal-title":"Nature Reviews Clinical Oncology"},{"issue":"4","key":"627_CR41","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.neuron.2014.10.011","volume":"84","author":"M Shariatgorji","year":"2014","unstructured":"Shariatgorji, M., A. Nilsson, R.J. Goodwin, P. Kallback, N. Schintu, X. Zhang, A.R. Crossman, E. Bezard, P. Svenningsson, and P.E. Andren. 2014. Direct targeted quantitative molecular imaging of neurotransmitters in brain tissue sections. Neuron 84(4): 697\u2013707.","journal-title":"Neuron"},{"issue":"1","key":"627_CR42","first-page":"11","volume":"12","author":"EG Solon","year":"2010","unstructured":"Solon, E.G., A. Schweitzer, M. Stoeckli, and B. Prideaux. 2010. Autoradiography, MALDI-MS, and SIMS-MS imaging in pharmaceutical discovery and development. American Association of Pharmaceutical Scientists Journal 12(1): 11\u201326.","journal-title":"American Association of Pharmaceutical Scientists Journal"},{"issue":"8","key":"627_CR43","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1056\/NEJMoa1112302","volume":"366","author":"JA Sosman","year":"2012","unstructured":"Sosman, J.A., K.B. Kim, L. Schuchter, R. Gonzalez, A.C. Pavlick, J.S. Weber, G.A. McArthur, T.E. Hutson, S.J. Moschos, K.T. Flaherty, P. Hersey, R. Kefford, D. Lawrence, I. Puzanov, K.D. Lewis, R.K. Amaravadi, B. Chmielowski, H.J. Lawrence, Y. Shyr, F. Ye, J. Li, K.B. Nolop, R.J. Lee, A.K. Joe, and A. Ribas. 2012. Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib. New England Journal of Medicine 366(8): 707\u2013714.","journal-title":"New England Journal of Medicine"},{"issue":"17\u201318","key":"627_CR44","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1002\/pmic.201300476","volume":"14","author":"Y Sugihara","year":"2014","unstructured":"Sugihara, Y., A. Vegvari, C. Welinder, G. Jonsson, C. Ingvar, L. Lundgren, H. Olsson, T. Breslin, E. Wieslander, T. Laurell, M. Rezeli, B. Jansson, T. Nishimura, T.E. Fehniger, B. Baldetorp, and G. Marko-Varga. 2014. A new look at drugs targeting malignant melanoma\u2014An application for mass spectrometry imaging. Proteomics 14(17\u201318): 1963\u20131970.","journal-title":"Proteomics"},{"issue":"16","key":"627_CR45","doi-asserted-by":"crossref","first-page":"8473","DOI":"10.1021\/ac502217r","volume":"86","author":"JG Swales","year":"2014","unstructured":"Swales, J.G., J.W. Tucker, N. Strittmatter, A. Nilsson, D. Cobice, M.R. Clench, C.L. Mackay, P.E. Andren, Z. Takats, P.J. Webborn, and R.J. Goodwin. 2014. Mass spectrometry imaging of cassette-dosed drugs for higher throughput pharmacokinetic and biodistribution analysis. Analytical Chemistry 86(16): 8473\u20138480.","journal-title":"Analytical Chemistry"},{"issue":"13","key":"627_CR46","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1002\/rcm.6256","volume":"26","author":"N Takai","year":"2012","unstructured":"Takai, N., Y. Tanaka, K. Inazawa, and H. Saji. 2012. Quantitative analysis of pharmaceutical drug distribution in multiple organs by imaging mass spectrometry. Rapid Communications in Mass Spectrometry 26(13): 1549\u20131556.","journal-title":"Rapid Communications in Mass Spectrometry"},{"issue":"4","key":"627_CR47","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1111\/bph.12990","volume":"172","author":"S T\u00f6r\u00f6k","year":"2015","unstructured":"T\u00f6r\u00f6k, S., \u00c1. V\u00e9gv\u00e1ri, M. Rezeli, T.E. Fehniger, J. T\u00f3v\u00e1ri, S. Paku, V. Laszlo, B. Hegedus, A. Rozsas, B. Dome, and G. Marko-Varga. 2015. Localization of sunitinib, its metabolites and its target receptors in tumour-bearing mice: A MALDI-MS imaging study. British Journal of Pharmacology 172(4): 1148\u20131163.","journal-title":"British Journal of Pharmacology"},{"issue":"10","key":"627_CR48","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1056\/NEJMra041245","volume":"351","author":"H Tsao","year":"2004","unstructured":"Tsao, H., M.B. Atkins, and A.J. Sober. 2004. Management of cutaneous melanoma. New England Journal of Medicine 351(10): 998\u20131012.","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"627_CR49","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/2001-1326-2-7","volume":"2","author":"C Welinder","year":"2013","unstructured":"Welinder, C., G. Jonsson, C. Ingvar, L. Lundgren, H. Olsson, T. Breslin, A. Vegvari, T. Laurell, M. Rezeli, B. Jansson, B. Baldetorp, and G. Marko-Varga. 2013. Establishing a Southern Swedish Malignant Melanoma OMICS and biobank clinical capability. Clinical and Translational Medicine 2(1): 7.","journal-title":"Clinical and Translational Medicine"},{"issue":"4","key":"627_CR50","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/path.2771","volume":"222","author":"SM Willems","year":"2010","unstructured":"Willems, S.M., A. van Remoortere, R. van Zeijl, A.M. Deelder, L.A. McDonnell, and P.C. Hogendoorn. 2010. Imaging mass spectrometry of myxoid sarcomas identifies proteins and lipids specific to tumour type and grade, and reveals biochemical intratumour heterogeneity. Journal of Pathology 222(4): 400\u2013409.","journal-title":"Journal of Pathology"},{"key":"627_CR51","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1038\/srep03050","volume":"3","author":"M Yasunaga","year":"2013","unstructured":"Yasunaga, M., M. Furuta, K. Ogata, Y. Koga, Y. Yamamoto, M. Takigahira, and Y. Matsumura. 2013. The significance of microscopic mass spectrometry with high resolution in the visualisation of drug distribution. Scientific Reports 3: 3050.","journal-title":"Scientific Reports"},{"issue":"4","key":"627_CR52","doi-asserted-by":"crossref","first-page":"e92831","DOI":"10.1371\/journal.pone.0092831","volume":"9","author":"H Ye","year":"2014","unstructured":"Ye, H., R. Mandal, A. Catherman, P.M. Thomas, N.L. Kelleher, C. Ikonomidou, and L. Li. 2014. Top-down proteomics with mass spectrometry imaging: A pilot study towards discovery of biomarkers for neurodevelopmental disorders. PLoS ONE 9(4): e92831.","journal-title":"PLoS ONE"},{"issue":"1","key":"627_CR53","doi-asserted-by":"crossref","first-page":"e86706","DOI":"10.1371\/journal.pone.0086706","volume":"9","author":"T Young","year":"2014","unstructured":"Young, T., A. Rohwer, J. Volmink, and M. Clarke. 2014. What are the effects of teaching evidence-based health care (EBHC)? Overview of systematic reviews. PLoS One 9(1): e86706.","journal-title":"PLoS One"}],"container-title":["Archives of Pharmacal Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12272-015-0627-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12272-015-0627-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12272-015-0627-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T03:38:27Z","timestamp":1717990707000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12272-015-0627-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,23]]},"references-count":54,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["627"],"URL":"https:\/\/doi.org\/10.1007\/s12272-015-0627-2","relation":{},"ISSN":["0253-6269","1976-3786"],"issn-type":[{"value":"0253-6269","type":"print"},{"value":"1976-3786","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,23]]}}}